Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A M Slater

Showing results (11-20 of 17) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 17 results.
The British Journal of Ophthalmology|May 1, 1995
Visual deficits in children born at less than 32 weeks' gestation with and without major ocular pathology and cerebral damageH J Dowdeswell, A M Slater, J Broomhall, et al.
The Biochemical Journal|February 1, 1983
Binding of platelet factor 4 to heparin oligosaccharidesJ Denton, D A Lane, L Thunberg, et al.
Journal of Experimental Child Psychology|April 15, 2000
The role of good form in young Infants' perception of partly occluded objectsS P Johnson, J G Bremner, A M Slater, et al.
Journal of Medicinal Chemistry|January 1, 1991
2-(3,4-Dichlorophenyl)-N-methyl-N-[2-(1-pyrrolidinyl)-1-substituted- ethyl]-acetamides: the use of conformational analysis in the development of a novel series of potent opioid kappa agonistsG F Costello, R James, J S Shaw, et al.
Biochemical Pharmacology|August 17, 1994
Epidermal growth factor receptor tyrosine kinase. Investigation of catalytic mechanism, structure-based searching and discovery of a potent inhibitorW H Ward, P N Cook, A M Slater, et al.
Journal of Medicinal Chemistry|September 1, 1990
1,2,4-Triazolo[4,3-a]pyrazine derivatives with human renin inhibitory activity. 2. Synthesis, biological properties and molecular modeling of hydroxyethylene isostere derivativesR H Bradbury, J S Major, A A Oldham, et al.
Advances in Experimental Medicine and Biology|January 1, 1993
Substituted-2-desamino-2-methyl-quinazolinones. A series of novel antitumour agentsF T Boyle, Z S Matusiak, L R Hughes, et al.
Pageof 2

Showing results (11-20 of 17) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 17 results.
The British Journal of Ophthalmology|May 1, 1995
Visual deficits in children born at less than 32 weeks' gestation with and without major ocular pathology and cerebral damageH J Dowdeswell, A M Slater, J Broomhall, et al.
The Biochemical Journal|February 1, 1983
Binding of platelet factor 4 to heparin oligosaccharidesJ Denton, D A Lane, L Thunberg, et al.
Journal of Experimental Child Psychology|April 15, 2000
The role of good form in young Infants' perception of partly occluded objectsS P Johnson, J G Bremner, A M Slater, et al.
Journal of Medicinal Chemistry|January 1, 1991
2-(3,4-Dichlorophenyl)-N-methyl-N-[2-(1-pyrrolidinyl)-1-substituted- ethyl]-acetamides: the use of conformational analysis in the development of a novel series of potent opioid kappa agonistsG F Costello, R James, J S Shaw, et al.
Biochemical Pharmacology|August 17, 1994
Epidermal growth factor receptor tyrosine kinase. Investigation of catalytic mechanism, structure-based searching and discovery of a potent inhibitorW H Ward, P N Cook, A M Slater, et al.
Journal of Medicinal Chemistry|September 1, 1990
1,2,4-Triazolo[4,3-a]pyrazine derivatives with human renin inhibitory activity. 2. Synthesis, biological properties and molecular modeling of hydroxyethylene isostere derivativesR H Bradbury, J S Major, A A Oldham, et al.
Advances in Experimental Medicine and Biology|January 1, 1993
Substituted-2-desamino-2-methyl-quinazolinones. A series of novel antitumour agentsF T Boyle, Z S Matusiak, L R Hughes, et al.
Pageof 2